Introduction:

Helicobacter pylori exhibit variations in antibiotic resistance in America and Colombia. Despite the use of various treatment regimens containing amoxicillin in the department of Antioquia, Colombia, as well as in several countries across the continent, the pattern of genotypic and phenotypic susceptibility to this antibiotic remains unknown.

Objective:

To determine the frequency of H. pylori infection by detecting the ureA gene and amoxicillin susceptibility through beta-lactamases in H. pylori isolates from patients with gastroduodenal diseases in Antioquia-Colombia.

Methods:

Cross-sectional analytical study with 179 patients attending endoscopy units of seven healthcare institutions. Sociodemographic and risk factor data were collected. Moreover, biopsies from the antrum and body were taken for microbiological isolation and molecular detection of H. pylori. The sociodemographic data were assessed through frequency analysis and bivariate statistics. DNA obtained from the biopsies was amplified by PCR for the ureA gene, and beta-lactamase production was evaluated using the nitrocefin test as well as the amplification of the TEM and SHV genes.

Results:

It was found that 61 % (109 / 179) of patients tested positive for H. pylori; out of 84 isolates obtained by culture, none tested positive for the nitrocefin test. Significant differences were found in socioeconomic status, healthcare system, and geographical location in patients positive for the ureA gene. Two patients tested positive for molecular detection of beta-lactamases from biopsies; however, SHV and TEM genes were not found in any isolate.

Conclusions:

The frequency of H. pylori for ureA-gene detection is higher than previous studies and similar to other reports in other Colombian regions; consequently, this will become a good diagnostic test in the country. Finally, none of the H. pylori isolates tested positive for beta-lactamases TEM and SHV.